Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
Magnesium and the regulation of muscle contraction
Systemic anticoagulation is usually needed to reduce the risk of thrombus formation in the fibrillating atrium and downstream embolization
This results in persistent swelling and the formation of subcutaneous lumps